- 全部删除
- 您的购物车当前为空
CAY10434是一种有作用的 CYP4A 羟化酶 (CYP4A hydroxylase) 抑制剂,在人肾微粒体测试中的 IC50值为8.8 nM。CAY 10434 在改善血管紧张素 II 的收缩过程中 Emax 为 6764 mg。
为众多的药物研发团队赋能,
让新药发现更简单!
CAY10434是一种有作用的 CYP4A 羟化酶 (CYP4A hydroxylase) 抑制剂,在人肾微粒体测试中的 IC50值为8.8 nM。CAY 10434 在改善血管紧张素 II 的收缩过程中 Emax 为 6764 mg。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 218 | In stock | |
5 mg | ¥ 525 | In stock | |
10 mg | ¥ 931 | In stock | |
25 mg | ¥ 1,580 | In stock | |
50 mg | ¥ 2,270 | In stock | |
100 mg | ¥ 3,210 | In stock | |
200 mg | ¥ 4,320 | In stock |
CAY10434 相关产品
产品描述 | CAY10434 is an active inhibitor of CYP4A hydroxylase with an IC50 value of 8.8 nM in human kidney microsomal test. The maximum contractile value (Emax) of CAY 10434 was 6764 mg in improving the contractile process of angiotensin II. |
分子量 | 287.4 |
分子式 | C17H25N3O |
CAS No. | 769917-29-5 |
Smiles | O(CCCCCCN(C)C)C1=CC=C(C=C1)N2C=CN=C2 |
存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
溶解度信息 | DMF: 18 mg/mL (62.63 mM), Sonication is recommended. DMSO: 10.8 mg/mL (37.58 mM), Sonication is recommended. DMf:PBS (pH 7.2)(1:3): 0.2 mg/mL (0.7 mM), Sonication is recommended. Ethanol: 13.5 mg/mL (46.97 mM), Sonication is recommended. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容